Published in Urology on October 01, 2007
The transient receptor potential channel TRPA1: from gene to pathophysiology. Pflugers Arch (2012) 1.63
The TRPV4 cation channel mediates stretch-evoked Ca2+ influx and ATP release in primary urothelial cell cultures. J Biol Chem (2009) 1.61
TRP channels in lower urinary tract dysfunction. Br J Pharmacol (2014) 1.48
Afferent nerve regulation of bladder function in health and disease. Handb Exp Pharmacol (2009) 1.42
Changes in afferent activity after spinal cord injury. Neurourol Urodyn (2010) 1.26
Transient receptor potential (TRP) channels: a clinical perspective. Br J Pharmacol (2014) 1.25
Urothelial signaling. Auton Neurosci (2009) 1.22
Functional TRP and ASIC-like channels in cultured urothelial cells from the rat. Am J Physiol Renal Physiol (2009) 1.19
From urgency to frequency: facts and controversies of TRPs in the lower urinary tract. Nat Rev Urol (2011) 1.01
Is the urothelium intelligent? Neurourol Urodyn (2010) 0.98
Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics. Br J Pharmacol (2014) 0.91
The use of cystometry in small rodents: a study of bladder chemosensation. J Vis Exp (2012) 0.87
Transcriptional and translational plasticity in rodent urinary bladder TRP channels with urinary bladder inflammation, bladder dysfunction, or postnatal maturation. J Mol Neurosci (2012) 0.87
Prospective pharmacologic therapies for the overactive bladder. Ther Adv Urol (2009) 0.83
Acupuncture for visceral pain: neural substrates and potential mechanisms. Evid Based Complement Alternat Med (2014) 0.82
The role of TRPA1 in visceral inflammation and pain. Channels (Austin) (2011) 0.82
Cyclophosphamide-induced cystitis reduces ASIC channel but enhances TRPV1 receptor function in rat bladder sensory neurons. J Neurophysiol (2013) 0.82
New insights into the pharmacology of the bladder. Curr Opin Urol (2008) 0.81
Crucial role of TRPC1 and TRPC4 in cystitis-induced neuronal sprouting and bladder overactivity. PLoS One (2013) 0.80
Comparison between sensory testing modalities for the evaluation of afferent nerve functioning in the genital area. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.79
Targeting Pain-evoking Transient Receptor Potential Channels for the Treatment of Pain. Curr Neuropharmacol (2013) 0.78
Receptors, channels, and signalling in the urothelial sensory system in the bladder. Nat Rev Urol (2016) 0.77
TRPA1-dependent regulation of bladder detrusor smooth muscle contractility in normal and type I diabetic rats. J Smooth Muscle Res (2016) 0.75
Redox-sensitive transient receptor potential channels in oxygen sensing and adaptation. Pflugers Arch (2015) 0.75
Hydrogen peroxide preferentially activates capsaicin-sensitive high threshold afferents via TRPA1 channels in the guinea pig bladder. Br J Pharmacol (2016) 0.75
Intrathecal administration of TRPA1 antagonists attenuate cyclophosphamide-induced cystitis in rats with hyper-reflexia micturition. BMC Urol (2016) 0.75
Emerging Families of Ion Channels Involved in Urinary Bladder Nociception. Pharmaceuticals (Basel) (2010) 0.75
Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab. Sci Transl Med (2011) 4.51
Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score. Urology (2006) 2.63
The TRPV4 cation channel mediates stretch-evoked Ca2+ influx and ATP release in primary urothelial cell cultures. J Biol Chem (2009) 1.61
Phase III, randomised, double-blind, placebo-controlled study of the β3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder. BJU Int (2014) 1.57
The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria. Clin Auton Res (2003) 1.53
Changes in dopaminergic and glutamatergic excitatory mechanisms of micturition reflex after middle cerebral artery occlusion in conscious rats. Exp Neurol (2002) 1.48
Small in-frame deletion in the epidermal growth factor receptor as a target for ZD6474. Cancer Res (2004) 1.39
Clinical guidelines for overactive bladder. Int J Urol (2009) 1.27
Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Res Treat (2006) 1.25
Switching addictions between HER2 and FGFR2 in HER2-positive breast tumor cells: FGFR2 as a potential target for salvage after lapatinib failure. Biochem Biophys Res Commun (2011) 1.13
Nitric oxide-mediated regulation of connexin43 expression and gap junctional intercellular communication in mesangial cells. J Am Soc Nephrol (2004) 1.12
Differential expression profile of cold (TRPA1) and cool (TRPM8) receptors in human urogenital organs. Urology (2008) 1.10
Endovascular treatment of ureteroarterial fistulas with stent-grafts. Radiat Med (2008) 1.08
Suppression of NF-kappaB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response. J Immunol (2009) 1.05
Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score. Urology (2010) 1.05
Clinical guideline for male lower urinary tract symptoms. Int J Urol (2009) 1.02
Solifenacin as add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms--ASSIST, randomized controlled study. Urology (2011) 1.01
Coordinate control of prostaglandin E2 synthesis and uptake by hyperosmolarity in renal medullary interstitial cells. Am J Physiol Renal Physiol (2005) 1.00
Rapid, transient induction of ER stress in the liver and kidney after acute exposure to heavy metal: evidence from transgenic sensor mice. FEBS Lett (2007) 0.99
Overexpression of epithelial sodium channels in epithelium of human urinary bladder with outlet obstruction. Urology (2004) 0.98
Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly. Clin Ther (2005) 0.97
Association of the expression of mutant epidermal growth factor receptor protein as determined with mutation-specific antibodies in non-small cell lung cancer with progression-free survival after gefitinib treatment. J Thorac Oncol (2012) 0.97
The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients. Am J Kidney Dis (2003) 0.96
Metastatic uveal tumor secondary to testicular choriocarcinoma. Jpn J Ophthalmol (2004) 0.93
Continuous, noninvasive monitoring of local microscopic inflammation using a genetically engineered cell-based biosensor. Lab Invest (2005) 0.93
Human muscarinic receptor binding characteristics of antimuscarinic agents to treat overactive bladder. J Urol (2006) 0.92
Ejaculation disorder is associated with increased efficacy of silodosin for benign prostatic hyperplasia. Urology (2010) 0.92
Tolerability of nintedanib (BIBF 1120) in combination with docetaxel: a phase 1 study in Japanese patients with previously treated non-small-cell lung cancer. J Thorac Oncol (2015) 0.92
DRESSA: biosensing of dioxin and dioxin-like chemicals using secreted alkaline phosphatase. Anal Biochem (2004) 0.92
Involvement of hypoxia-triggered endoplasmic reticulum stress in outlet obstruction-induced apoptosis in the urinary bladder. Lab Invest (2008) 0.92
Amiloride-sensitive ion channels in urinary bladder epithelium involved in mechanosensory transduction by modulating stretch-evoked adenosine triphosphate release. Urology (2007) 0.91
Expression of PGT in MDCK cell monolayers: polarized apical localization and induction of active PG transport. Am J Physiol Renal Physiol (2002) 0.91
Change in muscarinic modulation of transmitter release in the rat urinary bladder after spinal cord injury. Neurochem Int (2003) 0.90
Synergistic effects of PDGF-BB and cAMP-elevating agents on expression of connexin43 in mesangial cells. Am J Physiol Renal Physiol (2005) 0.89
Real-time monitoring of mesangial cell-macrophage cross-talk using SEAP in vitro and ex vivo. Kidney Int (2005) 0.89
Selection of autophagy or apoptosis in cells exposed to ER-stress depends on ATF4 expression pattern with or without CHOP expression. Biol Open (2013) 0.88
Roles of mechanosensitive ion channels in bladder sensory transduction and overactive bladder. Int J Urol (2008) 0.88
Sex-related differences in activity of lower urinary tract in response to intravesical acid irritation in decerebrate unanesthetized mice. Am J Physiol Regul Integr Comp Physiol (2008) 0.88
Reciprocal regulation between proinflammatory cytokine-induced inducible NO synthase (iNOS) and connexin43 in bladder smooth muscle cells. J Biol Chem (2011) 0.88
Effects of urethane on reflex activity of lower urinary tract in decerebrate unanesthetized rats. Am J Physiol Renal Physiol (2012) 0.87
Treatment of abdominal malignancy invading the vena cava: a report of seven cases. Surg Today (2007) 0.87
Sex differences in the expression profile of acid-sensing ion channels in the mouse urinary bladder: a possible involvement in irritative bladder symptoms. BJU Int (2009) 0.87
Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system. Br J Pharmacol (2006) 0.87
Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer. Int J Urol (2006) 0.87
Relationship of bladder dysfunction to lesion site in multiple sclerosis. J Urol (2003) 0.87
Expression changes in arrestin β 1 and genetic variation in catechol-O-methyltransferase are biomarkers for the response to morphine treatment in cancer patients. Oncol Rep (2012) 0.85
Current and future directions in diagnostic markers in interstitial cystitis. Int J Urol (2003) 0.84
Functional roles of TRPV1 channels in lower urinary tract irritated by acetic acid: in vivo evaluations of the sex difference in decerebrate unanesthetized mice. Am J Physiol Renal Physiol (2010) 0.84
A novel mass spectrometry-based assay for diagnosis of EML4-ALK-positive non-small cell lung cancer. J Thorac Oncol (2012) 0.84
Nonsteroidal anti-inflammatory drug flufenamic acid is a potent activator of AMP-activated protein kinase. J Pharmacol Exp Ther (2011) 0.84
Prospective study evaluating the plasma concentrations of twenty-six cytokines and response to morphine treatment in cancer patients. Anticancer Res (2011) 0.84
Incontinence and detrusor dysfunction associated with pelvic organ prolapse: clinical value of preoperative urodynamic evaluation. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.84
Intraperitoneal rupture of giant hydronephrosis due to ureteral cancer accompanied by renal cell carcinoma. J Urol (2002) 0.83
5'-AMP-activated protein kinase attenuates adriamycin-induced oxidative podocyte injury through thioredoxin-mediated suppression of the apoptosis signal-regulating kinase 1-P38 signaling pathway. Mol Pharmacol (2013) 0.83
Predictive factors for the effect of the α1-D/A adrenoceptor antagonist naftopidil on subjective and objective criteria in patients with neurogenic lower urinary tract dysfunction. BJU Int (2010) 0.83
Micturition-related electrophysiological properties in the substantia nigra pars compacta and the ventral tegmental area in cats. Auton Neurosci (2002) 0.82
Inhibition of c-Jun N-terminal kinase ameliorates apoptosis induced by hydrogen peroxide in the kidney tubule epithelial cells (NRK-52E). Nephron (2002) 0.81
Defining overactive bladder as hypersensitivity. Neurourol Urodyn (2007) 0.81
Purinergic control of AMPK activation by ATP released through connexin 43 hemichannels - pivotal roles in hemichannel-mediated cell injury. J Cell Sci (2014) 0.81
A novel salvage technique that does not require catheter removal for exit-site infection. Perit Dial Int (2002) 0.81
Diagnosis and treatment of voiding symptoms. Urology (2003) 0.80
Decreased expression of the epithelial Ca2+ channel TRPV5 and TRPV6 in human renal cell carcinoma associated with vitamin D receptor. J Urol (2011) 0.80
Multifocal metastases of recurrent renal cell carcinoma successfully treated with a combination of low dose interleukin-2, alpha-interferon and radiotherapy. Int J Urol (2005) 0.80
Self-reversed parallel wire balloon technique for dilating unyielding strictures in native dialysis fistulas. J Vasc Interv Radiol (2002) 0.80
ZD6474 inhibits tumor growth and intraperitoneal dissemination in a highly metastatic orthotopic gastric cancer model. Int J Cancer (2006) 0.80
Long-term gefitinib treatment of occult lung carcinoma with multiple brain metastases. Lung Cancer (2012) 0.80
Firing patterns of micturition-related neurons in the pontine storage centre in cats. Auton Neurosci (2002) 0.80
β-Catenin signaling contributes to platelet derived growth factor elicited bladder smooth muscle cell contraction through up-regulation of Cx43 expression. J Urol (2012) 0.79
Phase I trial of OTS11101, an anti-angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor. Cancer Sci (2012) 0.79
A string pattern regression algorithm and its application to pattern discovery in long introns. Genome Inform (2002) 0.79
Phase I and pharmacokinetic study of gefitinib and S-1 combination therapy for advanced adenocarcinoma of the lung. Cancer Chemother Pharmacol (2013) 0.78
Connexin43 hemichannel-mediated regulation of connexin43. PLoS One (2013) 0.78
Suppression of cell membrane permeability by suramin: involvement of its inhibitory actions on connexin 43 hemichannels. Br J Pharmacol (2014) 0.78
Retroperitoneoscopic nephron-sparing surgery of renal tumor using a microwave tissue coagulator without renal ischemia: comparison with open procedure. J Endourol (2003) 0.78
Feasibility study of two schedules of sunitinib in combination with pemetrexed in patients with advanced solid tumors. Invest New Drugs (2010) 0.78
Efficiently finding regulatory elements using correlation with gene expression. J Bioinform Comput Biol (2004) 0.78
Successful immune treatment for non-paraneoplastic limbic encephalitis. J Neurol Sci (2002) 0.78
Differential impact of lower urinary tract symptoms on generic and disease-specific quality of life in men and women. Urol Int (2008) 0.78